Cardiovascular Therapeutics

Research Article

Elevated Serum Total Bilirubin Might Indicate Poor Coronary Conditions for Unstable Angina Pectoris Patients beyond as a Cardiovascular Protector

Table 1

Clinical characteristics of UAP patients between different CCS-risk groups.
ParametersLow risk (CCS I-II, )High risk (CCS III-IV, ) value
Male (, %)86, 64.1%121, 74.6%<0.05
Age (years, ())<0.01
Hypertension (, %)61, 45.5%82, 50.6%0.38
Diabetes mellitus (, %)29, 21.6%31, 19.2%0.59
Current smokers (, %)66, 49.2%71, 43.8%0.35
BMI (kg/cm2)0.87
hs-CRP (mg/L)1.1 (0.5, 2.6)1.3 (0.6-3.3)<0.01
PLT (109/L)0.43
MPV (fL)10.8 (10.1-11.6)11.6 (11.1-12.7)<0.01
RBC (1012/L)4.4 (3.2-5.4)4.2 (3.5-5.9)0.87
WBC (109/L)7.4 (5.5-9.4)8.6 (5.7-10.5)0.34
NEUT (%)56.5 (44.6-77.3)65.2 (48.5-82.1)<0.01
RDW (%)12.8 (12.3-13.3)14.2 (13.6-15.7)<0.01
MCV (fL)93.6 (78.9-120.3)95.7 (80.1-123.5)0.18
FBG (mmol/L)5.7 (5.4-6.4)6.1 (5.5-8.3)<0.05
HBA1c (%)0.45
AST (U/L)0.32
ALT (U/L)0.11
Uric acid (μmol/L)220.3 (118.8-330.6)229.2 (120.5-345.6)0.22
SCR (μmol/L)62.3 (33.8-87.6)64.2 (34.1-88.5)0.15
STB (μmol/L)17.6 (15.6-20.1)20.5 (18.3-25.5)<0.01
GGT (U/L)27.5 (14.5-65.4)28.4 (17.1-63.2)0.14
TG (mmol/L)1.4 (0.7-3.4)1.3 (0.9-3.2)0.06
HDL-C (mmol/L)0.12
LDL-C (mmol/L)2.1 (1.5-2.7)2.7 (2.2-3.1)<0.05
D-dimers (mg/L)<0.01
CKMB (IU/L)0.22
TT (s)16.5 (14.2-22.216.3 (13.9-23.5)0.09
APTT (s)30.5 (25.5-39.7)29.6 (26.5-40.2)0.34
SYNTAX score<0.01
CTFC (frames)24.4 (15.1-28.2)26.4 (19.7-31.5)<0.05
Medications at admission
 Aspirin (, %)112, 83.5%138, 85.1%0.71
 Clopidogrel (, %)101, 75.4%121, 74.6%0.89
 ACEI/ARB (, %)93, 69.4%102, 62.9%0.26
 CCB (, %)88, 65.6%103, 63.5%0.71
 Beta-blockers (, %)92, 68.6%110, 67.9%0.89
 Stains (, %)87, 64.9%103, 63.5%0.81
RDW; red cell distribution width; WBC; white blood cell; MPV; mean platelet volume; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CRP; C-reactive protein; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprotein cholesterol.